Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01586104 · OUTCOME

Short-term Efficacy (Lung-metastases Free Survival, Overall Survival, Pulmonary Relapse, Deceased From Progressive Disease)

Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases · Source last updated 2025-02-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
From date of enrollment until the date of first documented progression, relapse or date of death from any cause up to an average of 3 years.

What was measured

Serial CT scans of the chest were examined to determine lung-metastasis free survival

Analysis population: Overall survival and incidence rates of additional relevant clinical data

Groups in this outcome

Treatment (IMRT)

Patients undergo cardiac-sparing whole lung intensity-modulated radiation therapy (IMRT).

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treatment (IMRT)20

Reported measurements

2yr overall survival

Analysis denominator · Participants

GroupSource count
Treatment (IMRT)20
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treatment (IMRT)18Not reportedNot reportedNot reportedNot reported
3yr overall survival

Analysis denominator · Participants

GroupSource count
Treatment (IMRT)20
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treatment (IMRT)18Not reportedNot reportedNot reportedNot reported
2yr lung-metastasis progression free survival

Analysis denominator · Participants

GroupSource count
Treatment (IMRT)20
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treatment (IMRT)13Not reportedNot reportedNot reportedNot reported
3yr lung-metastasis progression free survival

Analysis denominator · Participants

GroupSource count
Treatment (IMRT)20
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treatment (IMRT)10Not reportedNot reportedNot reportedNot reported
Pulmonary relapse

Analysis denominator · Participants

GroupSource count
Treatment (IMRT)20
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treatment (IMRT)8Not reportedNot reportedNot reportedNot reported
Pulmonary relapse - after primary therapy

Analysis denominator · Participants

GroupSource count
Treatment (IMRT)15
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treatment (IMRT)4Not reportedNot reportedNot reportedNot reported
Pulmonary relapse - after relapse/progression

Analysis denominator · Participants

GroupSource count
Treatment (IMRT)5
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treatment (IMRT)4Not reportedNot reportedNot reportedNot reported
Deceased from progressive disease

Analysis denominator · Participants

GroupSource count
Treatment (IMRT)20
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treatment (IMRT)2Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        18
    denoms
    1. counts
      1. group Id
        OG000
        value
        20
      units
      Participants
    title
    2yr overall survival
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        18
    denoms
    1. counts
      1. group Id
        OG000
        value
        20
      units
      Participants
    title
    3yr overall survival
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        13
    denoms
    1. counts
      1. group Id
        OG000
        value
        20
      units
      Participants
    title
    2yr lung-metastasis progression free survival
  4. categories
    1. measurements
      1. group Id
        OG000
        value
        10
    denoms
    1. counts
      1. group Id
        OG000
        value
        20
      units
      Participants
    title
    3yr lung-metastasis progression free survival
  5. categories
    1. measurements
      1. group Id
        OG000
        value
        8
    denoms
    1. counts
      1. group Id
        OG000
        value
        20
      units
      Participants
    title
    Pulmonary relapse
  6. categories
    1. measurements
      1. group Id
        OG000
        value
        4
    denoms
    1. counts
      1. group Id
        OG000
        value
        15
      units
      Participants
    title
    Pulmonary relapse - after primary therapy
  7. categories
    1. measurements
      1. group Id
        OG000
        value
        4
    denoms
    1. counts
      1. group Id
        OG000
        value
        5
      units
      Participants
    title
    Pulmonary relapse - after relapse/progression
  8. categories
    1. measurements
      1. group Id
        OG000
        value
        2
    denoms
    1. counts
      1. group Id
        OG000
        value
        20
      units
      Participants
    title
    Deceased from progressive disease
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    units
    Participants
description
Serial CT scans of the chest were examined to determine lung-metastasis free survival
groups
  1. description
    Patients undergo cardiac-sparing whole lung intensity-modulated radiation therapy (IMRT).
    id
    OG000
    title
    Treatment (IMRT)
param Type
COUNT_OF_PARTICIPANTS
population Description
Overall survival and incidence rates of additional relevant clinical data
reporting Status
POSTED
time Frame
From date of enrollment until the date of first documented progression, relapse or date of death from any cause up to an average of 3 years.
title
Short-term Efficacy (Lung-metastases Free Survival, Overall Survival, Pulmonary Relapse, Deceased From Progressive Disease)
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice